An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone on a weight-loss drug called Wegovy wrote that they lost about 6 kg over six months while eating less and strength training, but their weight stopped falling for the past three months while on a mid-level dose. Their prescriber offered a different medication called "5 mg MJ" (the snippet doesn’t make clear what that is) as an alternative, and they’re worried about side effects because they barely had any problems on Wegovy aside from mild nausea. There’s no trial data in the note — it’s one person asking for advice about whether to switch. Wegovy is the brand name for semaglutide, a drug that copies a gut hormone that helps you feel full and slows how fast your stomach empties. It’s given as a weekly injection and is prescribed for people trying to lose weight. The medication doesn’t burn fat on its own; it mostly helps reduce appetite and makes it easier to keep eating less. Doses are stepped up over time to balance effectiveness with side effects like nausea. From this short message we don’t have any new clinical study — just a single patient report of an initial decline in weight followed by a plateau. Weight loss commonly stalls after an initial drop because the body adapts: metabolism can slow, hunger signals can shift, and weight-loss medications sometimes reach a point of diminishing returns at a given dose. A prescriber suggesting a switch could mean trying a different drug or a higher dose to overcome that plateau, but the snippet doesn’t say whether “5 mg MJ” is a higher dose of semaglutide, a different class of drug, or something else. We also don’t know how long the person would stay on the new drug or what measurements (like body composition, calories, or exercise) were tracked. For a regular person, the practical takeaway is this: plateaus are common and don’t mean failure. Options include continuing the current dose longer, adjusting diet or exercise, checking for other medical factors (thyroid issues, medications, patterns of calorie intake), or trying a different medication or dose under guidance. If a doctor suggests switching drugs, it’s reasonable to ask what the alternative is, why they think it will help, how much extra benefit to expect, and what side effects to watch for. Caveats and risks are important. Wegovy/semaglutide has known side effects like nausea, vomiting, diarrhea, constipation, and, in rare cases, more serious issues such as pancreatitis or gallbladder problems. Different drugs or doses will have different profiles; some people tolerate one medication better than another. Stopping or switching medications can also lead to weight regain if appetite control loosens. Because the snippet doesn’t identify “5 mg MJ” or provide clinical data, we can’t say if it’s approved, how safe it is, or how effective it might be. Anyone considering a change should talk with their prescriber about the specific drug, realistic expectations, monitoring plans, and how to handle side effects. Bottom line: Weight-loss plateaus are normal; discuss clear reasons, expected benefits, and side effects with your clinician before switching medications.
Source: r/Semaglutide